MetaCap
John Hoeven official portrait

John Hoeven Stock Trades

U.S. SenatorRepublicanND

Trades on file
12
Buys / sells
7 / 5
Last trade
Jul 23, 2021
Typical amount
$100,001 – $250,000

John Hoeven's trading activity

Sen. John Hoeven, a Republican from ND, has 12 stock and securities transactions on file in periodic transaction reports filed under the STOCK Act. The most frequently reported tickers are BIV (1 trade), BMEZ (1 trade) and GTX (1 trade). Across all reported trades, 7 were purchases and 5 were sales (full or partial).

The most recent reported transaction is dated Jul 23, 2021, and the latest report was filed on Aug 11, 2021. The most common reported amount range is $100,001 – $250,000; the forms list value ranges rather than exact amounts.

Summary generated from market data by MetaCap's automated system. Methodology

Trades by year

John Hoeven trades by year
YearTrades
20211
20203
20198

Stocks John Hoeven trades most

Stocks most traded by John Hoeven
StockTradesBuysSells
BIVVanguard Intermediate-Term Bond ETF110
BMEZBlackRock Health Sciences Term110
GTXGarrett Motion101
KHCKraft Heinz101
MPCMarathon Petroleum110
REZIResideo Technologies101
SLBSLB110

John Hoeven trade history

Stock trades disclosed by John Hoeven
AssetTypeAmountTradedFiling
Northwest Respiratory Services, LLCotherSell$5,000,001 – $25,000,000Jul 23, 2021Filing for John Hoeven Northwest Respiratory Services, LLC trade
Westbrand, Inc.otherBuy$1,001 – $15,000Apr 29, 2020Filing for John Hoeven Westbrand, Inc. trade
Westbrand, Inc.otherBuy$15,001 – $50,000Apr 2, 2020Filing for John Hoeven Westbrand, Inc. trade
BMEZBlackRock Health Sciences Term TrustBuy$100,001 – $250,000Jan 29, 2020Filing for John Hoeven BMEZ trade
MPCMarathon Petroleum CorporationBuy$50,001 – $100,000Dec 31, 2019Filing for John Hoeven MPC trade
SLBSLB LimitedBuy$50,001 – $100,000Dec 31, 2019Filing for John Hoeven SLB trade
Vanguard GNMA Fund Admiral SharesstockBuy$50,001 – $100,000Dec 31, 2019Filing for John Hoeven Vanguard GNMA Fund Admiral Shares trade
BIVVanguard Intermediate-Term Bond ETFBuy$100,001 – $250,000Dec 31, 2019Filing for John Hoeven BIV trade
GTXGarrett Motion Inc.Sell$1,001 – $15,000Dec 23, 2019Filing for John Hoeven GTX trade
KHCThe Kraft Heinz CompanySell$100,001 – $250,000Dec 23, 2019Filing for John Hoeven KHC trade
REZIResideo Technologies Inc.Sell$1,001 – $15,000Dec 23, 2019Filing for John Hoeven REZI trade
Templeton Global Bond Fund Advisor ClassstockSell$100,001 – $250,000Dec 23, 2019Filing for John Hoeven Templeton Global Bond Fund Advisor Class trade

Source: House Clerk and Senate EFD public disclosures. Trades are reported as dollar ranges and may be disclosed up to 45 days after the transaction.

Frequently asked questions

What stocks does John Hoeven trade?
Based on STOCK Act disclosures, John Hoeven's most frequently reported holdings and trades include BIV, BMEZ, GTX, KHC and MPC. Disclosures show transactions, not a complete current portfolio, and may include assets held by a spouse or dependent child.
When did John Hoeven last report a trade?
The latest transaction on file is dated Jul 23, 2021 and the most recent report was filed on Aug 11, 2021. Members have up to 45 days after a trade to disclose it, so newer trades may not be public yet.
How many stock trades has John Hoeven disclosed?
MetaCap has 12 transactions on file for John Hoeven: 7 purchases and 5 sales.
How much money is involved in John Hoeven's trades?
Exact values are not disclosed. Each trade is reported within a dollar range, most commonly $100,001 – $250,000.
Where does this data come from?
Senate reports come from the Senate Electronic Financial Disclosure (EFD) system. Each row links to the original filing.

More Congress trading

Latest filing Aug 11, 2021. Source: House Clerk and Senate EFD public disclosures. Trades are reported as dollar ranges and may be disclosed up to 45 days after the transaction. Disclosures are shown as filed and are not a recommendation to buy or sell any security. Market data is delayed at least 15 minutes and provided for informational purposes only. Not investment advice. Full disclaimer